Dr. Nicholas Thomas Orfanidis, MD

Dr. Orfanidis practices at South Jersey Endoscopy in Woodbury, New Jersey.

Dr. Orfanidis' NPI, 1669638573, was assigned on July 30, 2008. Dr. Orfanidis graduated from Temple University School of Medicine in 2005. Dr. Orfanidis holds Pennsylvania license MT186282.

Dr. Orfanidis' primary practice is South Jersey Endoscopy, at 26 East Red Bank Avenue, Woodbury, NJ 08096. The practice phone is (856) 848-4464.

Dr. Orfanidis' primary practice is South Jersey Endoscopy in Woodbury, New Jersey. Dr. Orfanidis is also affiliated with Thomas Jefferson University Hospital. The medical group on file is DiMarino-Kroop-Prieto Gastrointestinal Associates. Dmand AI also links Dr. Orfanidis to 2 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orfanidis practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Orfanidis' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Orfanidis is licensed in Pennsylvania.

CMS data shows 1,056 Medicare services from Dr. Orfanidis across 13 procedure codes in 2024, for 599 Medicare patients. Medicare paid $103,079 for them.

CMS counts 599 Medicare patients who saw Dr. Orfanidis in 2024. The largest group is 65 to 74, with 244 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orfanidis' median patient age at 62, with 51% women.

In 2024, Dr. Orfanidis wrote 2,083 Medicare Part D claims for 480 patients. 83% of them were for generic drugs. CMS names the drug for 1,855 of them, across 36 drugs with 11 or more claims each, at $1,299,760 in total drug cost. In 2023, CMS named 1,856 claims across 34 drugs.

Dr. Orfanidis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orfanidis as offering telehealth. CMS counts 208 procedures of colonoscopy by Dr. Orfanidis, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Orfanidis in 2011. Dr. Orfanidis' most frequent co-authors are Eugene P. Kennedy, MD, Harish Lavu, MD and David E. Loren, MD.

CMS Open Payments shows 673 general payments to Dr. Orfanidis from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Merck Sharp & Dohme Corporation paid the most, $4,992.

Dr. Orfanidis graduated from Temple University School of Medicine in 2005.